Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Ann Arbor, Michigan 48109


This study is designed to test whether an alternative medicine treatment, fish oil, will prevent depressive symptoms in pregnant and postpartum women who have been found to be at risk for depression. Epidemiologists have observed that people who live in countries where people on average eat a diet high in fish have a lower risk of depression than people who live in populations that eat less fish. Postpartum depression is also less common in these countries. The omega-3 fatty acids found in fish oil are thought to be responsible for this beneficial effect of eating fish. The two major omega-3 fatty acids found in fish are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). DHA is an essential building block of the brain and nerve tissue. EPA may act to optimize the electrical signals between nerve cells and brain cells and may help the immune system to function well. Some researchers have treated people who are already suffering from depression with fish oil. Some of these studies have shown a benefit for the fish oil treatment and others have not. These studies have tested EPA and DHA alone and in various combinations. Currently, it is not known whether EPA or DHA is more effective in preventing and treating depression. Some of the researchers involved in this study have learned how to identify mothers who are most at risk for developing depression during and after pregnancy. This study is designed to learn whether EPA-rich and DHA-rich fish oil supplements will prevent depressive symptoms in women who are at risk to develop depression.


Inclusion Criteria: - Women who are more than 12 weeks pregnant but less than 20 weeks pregnant - Women who are found to be at risk for depression - Women who have been treated for depression in the past - Women with depression after a previous pregnancy - Women planning to deliver at University of Michigan Hospital Exclusion Criteria: - Women who have major depression or other psychiatric disorders (current substance abuse, schizophrenia, bipolar disorder) at the time of screening - Women who are currently taking anti-depressant or other psychiatric medications - Women who routinely eat more than 2 fish meals per week - Women on anticoagulants (blood thinners) - Women currently taking omega-3 fatty acid dietary supplements (fish oil, flaxseed oil or cod liver oil) - Women with bleeding disorders such as von Willebrand's disease - Women under the age of 18 - Women with a multiple gestation (twins, for example) - Women planning to deliver at another hospital - Women planning to move away before 6 weeks after delivery



Primary Contact:

Principal Investigator
Ellen Mozurkewich, MD, MS
University of Michigan

Backup Contact:


Location Contact:

Ann Arbor, Michigan 48109
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.